| Literature DB >> 30079388 |
S Fujii1,2, A Ishibe2, M Ota2, K Watanabe3, J Watanabe3, C Kunisaki2, I Endo3.
Abstract
BACKGROUND: The optimal level for inferior mesenteric artery ligation during anterior resection for rectal cancer is controversial. The aim of this randomized trial was to clarify whether the inferior mesenteric artery should be tied at the origin (high tie) or distal to the left colic artery (low tie).Entities:
Year: 2018 PMID: 30079388 PMCID: PMC6069351 DOI: 10.1002/bjs5.71
Source DB: PubMed Journal: BJS Open ISSN: 2474-9842
Figure 1CONSORT diagram for the trial. For high‐tie ligation the inferior mesenteric artery was divided at its origin from the abdominal aorta; for low‐tie ligation the inferior mesenteric artery was divided just after branching to the left colic artery. APR, abdominoperineal resection of rectum; ISR, intersphincteric resection of rectum
Patient and tumour characteristics
| High tie ( | Low tie ( | |
|---|---|---|
| Age (years) | 65·9(10·4) | 65·6(11·5) |
| Sex ratio (M : F) | 103 : 61 | 97 : 63 |
| ASA grade | ||
| 1 | 39 (23·8) | 53 (33·1) |
| 2 | 115 (70·1) | 95 (59·4) |
| 3 | 10 (6·1) | 12 (7·5) |
| ECOG performance status | ||
| 0 | 72 (43·9) | 78 (48·8) |
| 1 | 77 (47·0) | 61 (38·1) |
| 2 | 15 (9·1) | 21 (13·1) |
| Prognostic Nutrition Index | 52·3(6·9) | 52·2(5·3) |
| Concomitant disease | 116 (70·7) | 102 (63·8) |
| Second synchronous colonic cancer | 15 (9·1) | 18 (11·3) |
| Cardiovascular disease | 79 (48·2) | 71 (44·4) |
| Diabetes | 19 (11·6) | 30 (18·8) |
| Other | 57 (34·8) | 48 (30·0) |
| History of laparotomy | 21 (12·8) | 28 (17·5) |
| BMI (kg/m2) | 23·0(3·2) | 22·4(3·5) |
| Tumour location | ||
| Upper rectum | 107 (65·2) | 99 (61·9) |
| Lower rectum | 57 (34·8) | 61 (38·1) |
| Distance from anal verge (mm) | 88·7(32·9) | 89·6(37·0) |
| Tumour diameter (mm) | 41·5(20·8) | 41·9(20·5) |
| Histology | ||
| Papillary adenocarcinoma | 1 (0·6) | 1 (0·6) |
| Well differentiated adenocarcinoma | 81 (49·4) | 85 (53·1) |
| Moderately differentiated adenocarcinoma | 77 (47·0) | 65 (40·6) |
| Poorly differentiated adenocarcinoma | 1 (0·6) | 2 (1·3) |
| Mucinous adenocarcinoma | 3 (1·8) | 2 (1·3) |
| Carcinoid tumour | 1 (0·6) | 4 (2·5) |
| Small cell carcinoma | 0 (0) | 1 (0·6) |
| pTNM stage | ||
| 0 | 4 (2·4) | 6 (3·8) |
| 1 | 56 (34·1) | 54 (33·8) |
| 2 | 43 (26·2) | 36 (22·5) |
| 3 | 54 (32·9) | 56 (35·0) |
| 4 | 7 (4·3) | 8 (5·0) |
| Surgical approach | ||
| Open | 57 (34·8) | 52 (32·5) |
| Laparoscopic | 107 (65·2) | 108 (67·5) |
| Level of anastomosis from anal verge (cm) | 5·8(2·0) | 5·7(2·1) |
| Diverting stoma | 36 (22·0) | 47 (29·4) |
| Insertion of intraluminal drain from anus | 12 (7·3) | 19 (11·9) |
| Simultaneous resection of other organ | 6 (3·7) | 10 (6·3) |
| No. of linear stapler cartridges used | ||
| 1 | 120 (73·2) | 111 (69·4) |
| ≥ 2 | 44 (26·8) | 49 (30·6) |
| Pelvic side‐wall lymphadenectomy | 25 (15·2) | 22 (13·8) |
| Adjuvant chemotherapy | 39 (23·8) | 46 (28·8) |
Values in parentheses are percentages unless indicated otherwise;
values are mean(s.d.).
Some patients had more than one concomitant disease.
ECOG, Eastern Cooperative Oncology Group.
Short‐term outcomes
| High tie ( | Low tie ( |
| |
|---|---|---|---|
| Anastomotic leakage | |||
| All grades | 29 (17·7) | 26 (16·3) | 0·731 |
| Grade 2 or above | 16 (9·8) | 14 (8·8) | 0·755 |
| Grade 3 or above | 4 (2·4) | 8 (5·0) | 0·222 |
| Leakage grade | |||
| 1 | 13 (7·9) | 12 (7·5) | 0·432 |
| 2 | 12 (7·3) | 6 (3·8) | |
| 3 | 4 (2·4) | 7 (4·4) | |
| 4 | 0 (0) | 0 (0) | |
| 5 | 0 (0) | 1 (0·6) | |
| Mortality | 0 (0) | 1 (0·6) | 0·311 |
| Early complication (except leakage) | 61 (37·2) | 56 (35·0) | 0·681 |
| Surgical‐site infection | 8 (4·9) | 10 (6·3) | 0·590 |
| Ileus | 16 (9·8) | 8 (5·0) | 0·102 |
| Enteritis | 2 (1·2) | 2 (1·3) | 1·000 |
| Chylous ascites | 3 (1·8) | 5 (3·1) | 0·452 |
| Urinary tract infection | 1 (0·6) | 2 (1·3) | 0·547 |
| Urinary dysfunction | 4 (2·4) | 3 (1·9) | 0·727 |
| Conversion to open surgery | 6 of 107 (5·6) | 2 of 108 (1·9) | 0·142 |
| Estimated blood loss (ml) | 155(299) | 152(289) | 0·867 |
| Blood transfusion | 3 (1·8) | 3 (1·9) | 0·976 |
| Duration of surgery (min) | 209(67) | 206(59) | 0·672 |
| Duration of IMA tie from start (min) | 41(15) | 52(15) | < 0·001 |
| Duration of laparoscopic procedure (min) | 161(42) | 165(45) | 0·525 |
| Postoperative hospital stay (days) | 17(14) | 16(12) | 0·451 |
Values in parentheses are percentages unless indicated otherwise;
values are mean(s.d.). IMA, inferior mesenteric artery.
χ2 test, except
Student's t test.
Risk factors for anastomotic leakage in all grades
| Leakage | Univariable analysis | Multivariable analysis | ||||
|---|---|---|---|---|---|---|
| Yes ( | No ( | Odds ratio |
| Odds ratio |
| |
| Sex | ||||||
| M | 47 (23·5) | 153 (76·5) | 4·40 (2·00, 9·67) | < 0·001 | 4·36 (1·56, 12·18) | 0·005 |
| F | 8 (6·5) | 116 (93·5) | 1·00 (reference) | 1·00 (reference) | ||
| pT category | ||||||
| pTis–pT3 | 39 (14·8) | 225 (85·2) | 1·00 (reference) | 1·00 (reference) | ||
| pT4 | 16 (27) | 44 (73) | 2·11 (1·08, 4·11) | 0·028 | 1·57 (0·58, 4·24) | 0·371 |
| Blood transfusion | ||||||
| Yes | 4 (67) | 2 (33) | 10·28 (1·83, 57·59) | 1·27 (0·06, 25·97) | 0·875 | |
| No | 51 (16·0) | 267 (84·0) | 1·00 (reference) | 0·008 | 1·00 (reference) | |
| Conversion of laparoscopy | ||||||
| Yes | 4 (50) | 4 (50) | 5·09 (1·21, 21·34) | 3·14 (0·69, 14·25) | 0·139 | |
| No | 34 (16·4) | 173 (83·6) | 1·00 (reference) | 0·026 | 1·00 (reference) | |
| Distance of tumour from anal verge (mm) | 81(31) | 91(35) | 0·99 (0·98, 1·00) | 0·043 | 0·99 (0·98, 1·00) | 0·011 |
| No. of stapler firings | 1·30(0·56) | 1·49(0·64) | 1·64 (1·05, 2·56) | 0·031 | 1·09 (0·62, 1·91) | 0·765 |
Values in parentheses are percentages unless indicated otherwise;
values are mean(s.d.) and
95 per cent confidence intervals in parentheses.
Oncological quality of surgery
| High tie ( | Low tie ( |
| |
|---|---|---|---|
| No. of lymph nodes harvested | |||
| Total | 26·4(11·4) | 24·1(12·2) | 0·079 |
| IMA root nodes | 2·8(2·1) | 2·9(2·7) | 0·639 |
| Intermediate lymph nodes | 5·4(3·9) | 5·1(3·9) | 0·623 |
| Perirectal lymph nodes | 15·5(7·6) | 14·1(7·5) | 0·130 |
| Lymph node involvement at each station | |||
| IMA root nodes | 3 (1·8) | 5 (3·1) | 0·452 |
| Intermediate lymph nodes | 10 (6·1) | 8 (5·0) | 0·666 |
| Perirectal lymph nodes | 58 (35·4) | 55 (34·4) | 0·852 |
| IMA root nodes positive, intermediate nodes negative | 0 (0) | 1 (0·6) | 0·311 |
| Intermediate nodes positive, perirectal nodes negative | 1 (0·6) | 1 (0·6) | 0·986 |
| Pathological proximal margin (cm) | 13·4(5·5) | 12·5(4·9) | 0·110 |
| Pathological distal margin (cm) | 3·1(1·8) | 3·2(2·0) | 0·618 |
| Positive circumferential margin | 3 (1·8) | 5 (3·1) | 0·452 |
Values are mean(s.d.).
IMA, inferior mesenteric artery.
χ2 test, except
Student's t test.
Long‐term results
| High tie ( | Low tie ( |
| |
|---|---|---|---|
| 5‐year overall survival rate (%) | |||
| All stages | 87·2 | 89·4 | 0·386 |
| Stage 1 | 94·2 | 96·3 | 0·740 |
| Stage 2 | 87·8 | 84·6 | 0·965 |
| Stage 3 | 88·2 | 88·6 | 0·880 |
| Stage 4 | 28·6 | 72·9 | 0·109 |
| 5‐year relapse‐free survival rate (%) | |||
| All stages | 76·3 | 77·6 | 0·765 |
| Stage 1 | 94·2 | 86·5 | 0·187 |
| Stage 2 | 78·1 | 79·1 | 0·856 |
| Stage 3 | 66·2 | 72·9 | 0·314 |
Log rank test.